CHICAGO, IL (July 25, 2017) – Dermatologists of Central States (“DOCS”), a portfolio company of Sheridan Capital Partners (“Sheridan”), announced today that it has completed a partnership with Dermatology and Skin Surgery Center (“DSSC”), a Battle Creek, Michigan-based provider of medical dermatology and Mohs surgery.
“Sheridan and the DOCS team are thrilled to partner with DSSC,” said Jonathan Lewis, Partner of Sheridan Capital Partners. “The DSSC partnership represents a meaningful expansion of the Sheridan dermatology platform, and continues the Company’s growth in an adjacent geography. Drs. Donn and Esther LaTour of DSSC have built a tremendous practice that provides care in underserved markets, and we are grateful they chose to partner with DOCS.”
Dr. Donn LaTour, Co-founder and owner of DSSC, said, “Esther and I are thrilled to join the DOCS team, and we look forward to joining Dr. Michael Conroy and CEO John Macke as we serve patients and communities throughout Michigan, Indiana and Ohio.”
Dr. Michael Conroy, Chief Medical Officer of DOCS, added, “In DSSC, we found a practice that provides efficient, patient-centric care with an uncompromising commitment to excellence in the clinic. The other physician groups partnering with DOCS will be well served by learning from the providers at DSSC.”
The transaction was led by Lewis, Sean Dempsey, Tim Wheeler, and Beau Brace at Sheridan Capital Partners, and Macke, Conroy, and Steve Murdock at DOCS. Twin Brook Capital Partners served as Administrative Agent for a syndicate of lenders financing the transaction. McGuireWoods LLP served as legal counsel to Sheridan Capital Partners and DOCS. MHT Partners served as financial advisor to DSSC, and McDermott Will & Emery LLP served as legal counsel to DSSC. Terms of the transaction were not disclosed.
About Sheridan Capital Partners
Sheridan Capital Partners, headquartered in Chicago, Illinois, focuses on making private equity investments in leveraged buyouts, recapitalizations and large minority financings of growing lower middle market growth companies with enterprise values between $20 million and $150 million within the healthcare and consumer sectors.
Jonathan Lewis, Partner